Limited Competition: Small Grant Program for NIDDK K01/K08/K23/K25 Recipients (R03 Clinical Trial Optional)
Issued by National Institutes of Health · via Grants.gov — US federal funding opportunities
- Published
- 10 Jan 2025
- Closes
- 7 Jan 2028, 23:59 UTC
- Value
- USD 75,000
- Reference
- PAR-25-091
- Location
- United States
- Sector
- Healthcare & Pharma
Details
The National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) announces a program that provides NIDDK-supported K01, K08, K23, and K25 recipients the opportunity to apply for Small Grant (R03) support at some point during the latter years of their award period of their K award. Through the use of this mechanism, the NIDDK is seeking to enhance the capability of its K01, K08, K23, and K25 award recipients to conduct research as they complete their transition to fully independent investigator status. The R03 grant mechanism supports different types of projects, including pilot and feasibility studies; secondary analysis of existing data; small, self-contained research projects; development of research methodology; and development of new research technology. The R03 is, therefore, intended to support research projects that can be carried out in a short period of time with limited resources and that may provide preliminary data to support a subsequent R01, or equivalent, application. Eligibility: Other Eligible Applicants include the following: Alaska Native and Native Hawaiian Serving Institutions; Asian American Native American Pacific Islander Serving Institutions (AANAPISISs); Eligible Agencies of the Federal Government; Faith-based or Community-based Organizations; Hispanic-serving Institutions; Historically Black Colleges and Universities (HBCUs); Indian/Native American Tribal Governments (Other than Federally Recognized); Non-domestic (non-U.S.) Entities (Foreign Organizations); Regional Organizations; Tribally Controlled Colleges and Universities (TCCUs) ; U.S. Territory or Possession; Non-domestic (non-U.S.) Entities (Foreign Organizations) are not eligible to apply. Non-domestic (non-U.S.) components of U.S. Organizations are not eligible to apply. Foreign components, as defined in the NIH Grants Policy Statement, are allowed.
CFDA number(s): 93.847
Federal funding opportunity published on Grants.gov. Applications are submitted through Grants.gov — see the official listing.
Context for bidders
We hold 411 notices from National Institutes of Health, going back to May 2023 — 378 of them still open. They buy mostly in Healthcare & Pharma, Education & Training and Water & Environment. There are 369 open Healthcare & Pharma tenders in United States. This one closes in 466 days.
More from this buyer
- Pancreatic Cancer Detection Consortium: Management and Data Coordination Unit (U24 Clinical Trial Not Allowed)· closes 25 May
- NEI Translational Research Program for Therapeutics (R61/R33 Clinical Trial Not Allowed)· closes 16 Nov
- Pancreatic Cancer Detection Consortium: Research Units (U01 Clinical Trial Optional)· closes 5 Nov
- Limited Competition: NIH Research Evaluation and Commercialization Hubs (REACH) (SB0 Clinical Trial Optional)· closes 10 Nov
- NIH Brain Development Cohorts (NBDC) and Population Assessment of Tobacco and Health (PATH) Study Biospecimen Access (X01 Clinical Trial Not Allowed)· closes 17 Apr
Similar Healthcare & Pharma tenders
- Bag, Medical Instrument — 25 each, NSN 6545016918890· closes 5 Oct
- Scanner, Acquisition, TH — 1 each, NSN 6520017024522· closes 5 Oct
- Ventilator, Volume, Port — 6 each, NSN 6515017029684· closes 5 Oct
- Comprehensive Medical Services -FDC Houston — General Health Care Services· closes 17 Nov
- 2027 Southern Hemisphere Influenza Vaccine — Drugs and Biologicals· closes 14 Oct
Before you bid on this tender
A quick checklist to help you decide whether to bid and prepare a compliant submission for this healthcare & pharma opportunity. Always verify the details on the official source.
- Confirm the exact closing date and time (and time zone) on the official portal — deadlines are strict and can be revised by a corrigendum.
- Read the full notice and every attached document, including the scope, specifications and any bill of quantities or terms of reference.
- Check the eligibility criteria — prior similar experience, annual turnover, certifications and registrations — and make sure you qualify before investing effort.
- Prepare any earnest-money deposit (EMD) or bid security and the required formats early; missing or wrongly-formatted documents are a common cause of rejection.
- Note how bids must be submitted (online or physical), in what format, and whether a digital signature or portal registration is required.
- Watch for corrigenda and clarifications right up to the deadline — requirements and dates can change.
More Healthcare & Pharma tenders
- 西安交通大学医学院第一附属医院心理量表评估系统(心理ct)采购项目公开招标公告西安交通大学第一附属医院 · China
- 108 VideomanagementStädtisches Krankenhaus Kiel GmbH · Germany
- LOS 3 - 1.600 EA Katheter, arterielle Embolektomie, 5FBundesamt für Infrastruktur, Umweltschutz und Dienstleistungen der Bundeswehr · Germany
- arbeitsmedizinische Betreuung für die Kreisverwaltung CoesfeldKreis Coesfeld · Germany
- DFG Großgerät Koordinatenmessgerät mit Tomografieeinrichtung - Mikrofocus- ComputertomografRheinland-Pfälzische Technische Universität Kaiserslautern-Landau · Germany
FreeTender mirrors this notice for reference. Verify the details and bid on the official portal.
Verify & apply on the official portal →